Lightbridge(US:LTBR)2026-02-26 22:02Financial Data and Key Metrics Changes - As of December 31, 2025, the company held approximately $201.9 million in cash and cash equivalents, a significant increase from $40 million a year earlier, providing substantial financial resources for operations [14] - The company used approximately $14.3 million in operations during fiscal 2025, reflecting continued investment in the fuel development program [15] - The company raised $176 million in net proceeds through its at-the-market equity offering program and generated approximately $3.6 million in interest income, up from $1.3 million in the prior year [15][16] Business Line Data and Key Metrics Changes - The company achieved major fuel development milestones, including the start of irradiation testing of enriched uranium-zirconium alloy fuel material samples in the Advanced Test Reactor [4][6] - Significant expansion of work at Idaho National Laboratory included new projects such as fuel qualification plan review and post-irradiation examination of fuel material samples [8] Market Data and Key Metrics Changes - Nuclear power generated approximately 18% of U.S. electricity in 2024, making it the largest source of clean electricity in the country [18] - The U.S. and other countries have pledged to triple global nuclear capacity by 2050, with the U.S. aiming to quadruple domestic nuclear power generation by the same year [19] Company Strategy and Development Direction - The company is focused on commercializing advanced nuclear fuel and has strengthened its balance sheet while advancing strategic partnerships [4][21] - The collaboration with Oklo Inc. aims to explore spent fuel recycling, aligning with recent executive orders on nuclear policy [21] Management's Comments on Operating Environment and Future Outlook - The macro environment for nuclear energy has become increasingly favorable, with significant policy shifts supporting nuclear projects [17] - The company is well-positioned to deliver fuel technology that meets the industry's growing needs for enhanced power output and improved safety [21] Other Important Information - The company maintains a debt-free balance sheet with no convertible securities or dilutive debt instruments, allowing for flexibility in pursuing opportunities [16] - The irradiation testing program is expected to yield initial results by April-May 2026, with post-irradiation examinations planned for later in the year [12] Q&A Session Summary - No questions were submitted for this call, and the company expressed appreciation for the support of shareholders and the dedication of its team and partners [22]